Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

Recent & Breaking News (TSX:PRN)

Profound Medical to Participate in March Virtual Investor Conferences

GlobeNewswire February 25, 2021

Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

GlobeNewswire February 11, 2021

Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 - Conference Call to Follow

GlobeNewswire February 9, 2021

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues

GlobeNewswire January 5, 2021

Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®

GlobeNewswire December 21, 2020

Profound Medical Receives FDA HDE Approval for Sonalleve®

GlobeNewswire November 30, 2020

Profound Medical Announces Changes to its Board of Directors

GlobeNewswire November 30, 2020

Profound Medical to Participate in November Virtual Investor Healthcare Conferences

GlobeNewswire November 10, 2020

Profound Medical Announces Third Quarter 2020 Financial Results

GlobeNewswire November 5, 2020

Profound Medical to Release Third Quarter 2020 Financial Results on November 5 - Conference Call to Follow

GlobeNewswire October 15, 2020

Profound Medical to Present at the Cantor Virtual Global Healthcare Conference

GlobeNewswire September 9, 2020

Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference

GlobeNewswire August 10, 2020

Profound Medical Announces Second Quarter 2020 Financial Results

GlobeNewswire August 6, 2020

Profound Medical to Release Second Quarter 2020 Financial Results on August 6 - Conference Call to Follow

GlobeNewswire July 22, 2020

Profound Medical Announces Closing of Offering

GlobeNewswire July 21, 2020

Profound Medical Announces Pricing of Offering of Common Shares

GlobeNewswire July 15, 2020

Profound Medical Announces Proposed Offering of Common Shares

GlobeNewswire July 15, 2020

Profound Medical Annual and Special Meeting of Shareholders Voting Results

GlobeNewswire May 20, 2020

Profound Medical Announces First Quarter 2020 Financial Results

GlobeNewswire May 7, 2020

Profound Medical to Release First Quarter 2020 Financial Results on May 7 - Conference Call to Follow

GlobeNewswire April 16, 2020